US Stock MarketDetailed Quotes
ESLA Estrella Immunopharma
- 1.150
- +0.040+3.60%
Close Oct 4 16:00 ET
- 1.200
- +0.050+4.35%
Post 20:01 ET
41.62MMarket Cap-5721P/E (TTM)
1.190High1.000Low38.19KVolume1.100Open1.110Pre Close43.21KTurnover0.36%Turnover RatioLossP/E (Static)36.19MShares3.23052wk High9.75P/B12.19MFloat Cap0.81052wk Low--Dividend TTM10.60MShs Float33.000Historical High--Div YieldTTM17.12%Amplitude0.810Historical Low1.131Avg Price1Lot Size
Estrella Immunopharma Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -34.23%7.31M | 44.59%3.95M | -82.87%469.53K | -62.97%1.02M | -35.17%1.87M | 559.47%11.11M | 154.29%2.73M | 1,528.78%2.74M | 2,502.95%2.76M | 2.89M |
| Selling and administrative expenses | 382.69%3.2M | 172.56%424.45K | 277.66%444.53K | 536.85%945.17K | 394.92%1.39M | 123.86%663.19K | 382.74%155.73K | 745.08%117.71K | 358.08%148.41K | --280.26K |
| -General and administrative expense | 382.69%3.2M | 172.56%424.45K | 277.66%444.53K | 536.85%945.17K | 394.92%1.39M | 123.86%663.19K | 382.74%155.73K | 745.08%117.71K | 358.08%148.41K | --280.26K |
| Research and development costs | -60.68%4.11M | 36.85%3.53M | -99.05%25K | -97.11%75.46K | -81.44%483.47K | 652.37%10.45M | 147.22%2.58M | 1,306.35%2.62M | 3,448.49%2.61M | --2.61M |
| Operating profit | 34.23%-7.31M | -44.59%-3.95M | 82.87%-469.53K | 62.97%-1.02M | 35.17%-1.87M | -559.47%-11.11M | -154.29%-2.73M | -1,528.78%-2.74M | -2,502.95%-2.76M | -2.89M |
| Net non-operating interest income expense | ||||||||||
| Other net income (expense) | ||||||||||
| Income before tax | 34.23%-7.31M | -44.59%-3.95M | 82.87%-469.53K | 62.97%-1.02M | 35.17%-1.87M | -559.47%-11.11M | -154.29%-2.73M | -1,528.78%-2.74M | -2,502.95%-2.76M | -2.89M |
| Income tax | 1.63K | 1.63K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | 34.21%-7.31M | -44.65%-3.95M | 82.87%-469.53K | 62.97%-1.02M | 35.17%-1.87M | -559.47%-11.11M | -154.29%-2.73M | -1,528.78%-2.74M | -2,502.95%-2.76M | -2.89M |
| Net income continuous Operations | 34.21%-7.31M | -44.65%-3.95M | 82.87%-469.53K | 62.97%-1.02M | 35.17%-1.87M | -559.47%-11.11M | -154.29%-2.73M | -1,528.78%-2.74M | -2,502.95%-2.76M | ---2.89M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 34.21%-7.31M | -44.65%-3.95M | 82.87%-469.53K | 62.97%-1.02M | 35.17%-1.87M | -559.47%-11.11M | -154.29%-2.73M | -1,528.78%-2.74M | -2,502.95%-2.76M | -2.89M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 34.21%-7.31M | -44.65%-3.95M | 82.87%-469.53K | 62.97%-1.02M | 35.17%-1.87M | -559.47%-11.11M | -154.29%-2.73M | -1,528.78%-2.74M | -2,502.95%-2.76M | -2.89M |
| Basic earnings per share | 14.49%-0.27 | -67.53%-0.13 | 87.16%-0.01 | 61.69%-0.03 | 35.18%-0.0531 | -559.47%-0.3157 | -154.29%-0.0776 | -1,528.74%-0.0779 | -2,503.13%-0.0783 | -0.082 |
| Diluted earnings per share | 14.49%-0.27 | -67.53%-0.13 | 87.16%-0.01 | 61.69%-0.03 | 35.18%-0.0531 | -559.47%-0.3157 | -154.29%-0.0776 | -1,528.74%-0.0779 | -2,503.13%-0.0783 | -0.082 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data